Rani Therapeutics Holdings Inc (NASDAQ:RANI) Is Down -33.17 Percent Over The Past 30 Days: What’s Next?

NOVA

In last trading session, Rani Therapeutics Holdings Inc (NASDAQ:RANI) saw 0.38 million shares changing hands with its beta currently measuring 0.00. Company’s recent per share price level of $0.56 trading at $0.03 or 5.88% at ring of the bell on the day assigns it a market valuation of $32.22M. That closing price of RANI’s stock is at a discount of -860.71% from its 52-week high price of $5.38 and is indicating a premium of 17.86% from its 52-week low price of $0.46.

For Rani Therapeutics Holdings Inc (RANI), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Rani Therapeutics Holdings Inc (NASDAQ:RANI) trade information

Rani Therapeutics Holdings Inc’s shares saw a change of -59.12% in year-to-date performance and have moved 0.14% in past 5-day. Rani Therapeutics Holdings Inc (NASDAQ:RANI) showed a performance of -33.17% in past 30-days.

Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 94.4% to its current value. Analysts have been projecting 9 as a low price target for the stock while placing it at a high target of 28. It follows that stock’s current price would drop -1507.14% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1507.14% for stock’s current value.

Rani Therapeutics Holdings Inc (RANI) estimates and forecasts

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 4.78% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 10.67% while estimates for its earnings growth in next 5 years are of 24.06%.

Rani Therapeutics Holdings Inc (NASDAQ:RANI)’s Major holders

VANGUARD GROUP INC is the top institutional holder at RANI for having 0.71 million shares of worth $2.7 million. And as of 2024-06-30, it was holding 2.7265 of the company’s outstanding shares.

The second largest institutional holder is NAN FUNG GROUP HOLDINGS LTD, which was holding about 0.49 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.8959 of outstanding shares, having a total worth of $1.88 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 518.7 shares of worth $0.29 million or 1.55% of the total outstanding shares. The later fund manager was in possession of 262.83 shares on Mar 31, 2025 , making its stake of worth around $0.15 million in the company or a holder of 0.78% of company’s stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.